Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Videos
Filter by Topic
Interview with the Innovators
Webinars
2018 AONN+ Midyear Conference
2018 ASCO Insights
AVBCC
AVBCC 2016
Payer-Provider
Personalized Medicine
Pricing
SABCS 2017
EHA 2016
WCLC 2016 - Lung Cancer
View All Videos ›
Managing Cost and Patient Risk for Optimal Value-Bases Care
November 13, 2023
Webinars
Watch Video
Bringing Stakeholders Together Bringing Stakeholders Together
September 28, 2023
AVBCC
Watch Video
Why AVBCC?
March 22, 2023
AVBCC
Watch Video
Navigating Care Programs in the Post-OCM era
March 7, 2023
Webinars
Watch Video
Tackling Health Equity in Oncology
December 14, 2022
Webinars
Watch Video
Relapsed or Refractory FL: Best Practices for Active Surveillance & Reinforcement of Management Plans
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
October 4, 2022
Interview with the Innovators
Watch Video
Predicting High-Risk Disease Using Progression of Disease in 24 Months (POD24) and the Key Role of Repeat Biopsy to Exclude the Diagnosis of Transformation to a High-Grade Lymphoma in Patients with Relapsed Follicular Lymphoma
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 23, 2022
Interview with the Innovators
Watch Video
Broadening the Variety of Candidate Therapies for R/R Follicular Lymphoma Allows Optimal Personalized Rx Choice, While Patient-Directed Education Helps Attain Greatest Clinical Benefit
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 19, 2022
Interview with the Innovators
Watch Video
Criteria Used to Guide Treatment Decisions and Choice of Therapeutic Agents in Patients with Relapsed or Refractory Follicular Lymphoma
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 12, 2022
Interview with the Innovators
Watch Video
Specific Dysregulation of B-Cell Signaling in Follicular Lymphoma and Its Role in the Initiation and Progression of This Malignancy
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
September 6, 2022
Interview with the Innovators
Watch Video
Spectrum of Symptoms in Patients Newly Diagnosed with Follicular Lymphoma and the Role of Optimal Coordination of Care at Initial Presentation
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
August 31, 2022
Interview with the Innovators
Watch Video
Epidemiology and expected survivorship in follicular lymphoma and lack of reliable long-term outcome predictors at disease presentation
FEATURING:
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
August 23, 2022
Interview with the Innovators
Watch Video
The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients
FEATURING:
Tracy Baroni-Allmon, BS Pharm, JD
;
Andrea Ferris, MBA
;
Ryan Hohma, JD
;
Paul Jeffrey, PharmD
;
Robert Orlowski, MD, PhD
;
Andrew Robertson, PhD, JD
;
Nicholas J. Sarlis, MD, PhD, FACP
June 8, 2022
Webinars
Watch Video
How oncologists can control costs at the point of care
FEATURING:
Ajeet Gajra, MD, FACP
;
Stephanie Mayfield, PharmD
;
Kathy Oubre, MS
;
Tanya Park
March 14, 2022
Webinars
Watch Video
Navigators Have Lessons to Share
FEATURING:
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
December 30, 2021
AVBCC
Watch Video
Page 1 of 13
1
2
3
4
5
6
7
8
9
10
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma